Caplin Point Laboratories Limited (CAPLIPOINT.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Caplin Point Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3406
First IPO Date
June 23, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Venkatram Ganapathisu Bramanian | General Counsel, Company Secretary & Compliance Officer | 5.4M | 1982 |
| D. Muralidharan | Chief Financial Officer - Finance & Accounts | 5.4M | 1956 |
| Sridhar Ganesan | MD & Whole Time Director | 5.7M | 1955 |
| Neelakandan K. | President - API R&D - Hyderabad | 13.6M | 1981 |
| Anto Vijinth V. | Functional Head -HO, HR & Admin | 0 | N/A |
| Sathya Narayanan | Deputy Chief Financial Officer | 0 | N/A |
| R. Dinesh | Functional Head - HO, Production Planning & Inventory Control | 0 | N/A |
| S. Gunasakaran | President of Clinical Research Operations | 0 | N/A |
| Sivakumar Balasubramanian | Plant Head - Puducherry | 0 | 1981 |
| Sathish Krishnan | Vice President | 0 | 1978 |
Description
Caplin Point Laboratories Limited is a pharmaceutical firm actively involved in the development, manufacture, marketing, and export of both generic medications and proprietary branded products, primarily operating within India. Their extensive product portfolio encompasses a broad spectrum of pharmaceutical dosage forms, including various types of injections (liquid, lyophilized, IV infusions, powder for injection), oral preparations (tablets, liquid orals, capsules, softgel capsules, dry syrups), specialized applications (ophthalmic products, suppositories and ovules), and topical treatments (topicals, dermo cosmetics, inhalers). Beyond manufacturing, the company also manages an e-commerce platform named QueTenX. Established in 1990, Caplin Point Laboratories maintains its headquarters in Chennai, India.
